A study that analyzed data from nearly 15 000 patients with COVID-19 receiving four combinations of chloroquine, hydroxychloroquine, and antibiotics indicates the drug regimen may be doing more harm than good.
Twin antibodies show neutralizing activity against SARS-CoV-2
Scientists identify a cocktail of antibodies from a recovered COVID-19 patient’s blood sample that helped neutralize the SARS-CoV-2 virus in mice.
Why do some COVID-19 patients lose their sense of smell?
A new study explores how SARS-CoV-2 damages cells in the nasal cavity, altering infected individuals’ sense of smell.
Tracking and analysis of SARS-CoV-2 spike protein mutations
Understanding changes to the spike protein’s structure is critical to the development of an effective vaccine.
Timing of immune response to COVID-19 may contribute to disease severity
The interaction between the innate and the adaptive immune responses to COVID-19 may be impacting disease progression, and the answer might be to suppress them.
Step-by-step guide on how to make new antibody test published
Researchers publish detailed protocol on their new antibody test to be used by researchers and clinicians around the world.
Potential vaccines against COVID-19 on trial in UK and Germany
The two countries, in separate studies, begin human trials of potential vaccines against COVID-19.
Recruiting AI in the battle against SARS-CoV-2 and future pandemics
A new AI system can identify optimal combinations of drugs and dosages in a matter of days to help halt viral pandemics before they reach global scales.
Study finds remdesivir effective against a key enzyme of coronavirus that causes COVID-19
Remdesivir, an anti-viral agent known to be effective against MERS, is already in human trials as researchers search for a treatment for COVID-19.
Easing the ethical burden on doctors during the pandemic
How should doctors navigate murky ethical territory throughout the COVID-19 pandemic?